Coronavirus: Vaccination

(asked on 4th February 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he is taking steps to asses the effect of delaying the second Pfizer/Biontech vaccine dose on immunity levels in elderly people against the South African variant of covid-19.


Answered by
Nadhim Zahawi Portrait
Nadhim Zahawi
This question was answered on 15th February 2021

Industry led studies are ongoing to understand the level of protection the Pfizer and AstraZeneca vaccines will provide against variant strains of COVID-19. This will include immunological studies to understand the potential for protection from COVID-19 vaccines against variants and follow up of phase three trial participants in geographical areas where variants are circulating. Global surveillance systems, including systems within Public Health England, will be able to provide observational data on vaccine effectiveness against COVID-19 variants. These will be reviewed by the Joint Committee on Vaccination and Immunisation as they become available.

Reticulating Splines